Portfolio (Quarterly)
Guide ↗
SUPERSTRING CAPITAL MANAGEMENT LP
· CIK 0001931118| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | SION | SIONNA THERAPEUTICS INC | Healthcare | 63,156.0 | $2.8M | 1.75% | -78K | -55.2% | $43.99 | -86.7% |
| 22 | — | BRIGHT MINDS BIOSCIENCES INC | — | 30,456.0 | $2.1M | 1.35% | +17K | +128.8% | $70.20 | — |
| 23 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 257,675.0 | $1.4M | 0.86% | -109K | -29.7% | $5.29 | +13.6% |
| 24 | HELP | CYBIN INC | Healthcare | 204,424.0 | $1.4M | 0.85% | NEW | — | $6.61 | +84.3% |
| 25 | — | KINIKSA PHARMACEUTICALS INTL | — | 18,867.0 | $1.2M | 0.76% | NEW | — | $63.95 | — |
| 26 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 25,623.0 | $907K | 0.57% | NEW | — | $35.39 | -1.9% |
| 27 | TNXP | TONIX PHARMACEUTICALS HLDG C | Healthcare | 63,648.0 | $812K | 0.51% | — | — | $12.76 | +6.5% |
| 28 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 121,457.0 | $464K | 0.29% | — | — | $3.82 | -0.0% |
| 29 | SNSE | FAETH THERAPEUTICS INC | Healthcare | 14,175.0 | $354K | 0.22% | NEW | — | $25.00 | -44.6% |
| 30 | BOLD | BOUNDLESS BIO INC | Healthcare | 55,356.0 | $138K | 0.09% | NEW | — | $2.50 | +13.2% |
| 31 | BMEA | BIOMEA FUSION INC | Healthcare | 250,000.0 | $85K | 0.05% | — | — | $0.34 | +407.0% |
| 32 | — | VYNE THERAPEUTICS INC | — | 61,269.0 | $40K | 0.03% | NEW | — | $0.65 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%